Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily Interruption of Sedation vs No Sedation in Respiratory Failure
NCT03406936Completed
- Sponsor
- Assiut University
- Start
- Aug 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of midazolam in respiratory failure (2 arms), sponsored by Assiut University. Primary endpoint: Duration of mechanical ventilation at 30 days. Started Aug 2016; status: completed.
02
Drugs
midazolam
03
Conditions
respiratory failure
Beyond the preview
Go deeper on NCT03406936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03406936.